secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cigna Group (CI)
CIK:        0001739940
Form:       8-K
Filed at:   2026-09-30T11:12:36+00:00
Accession:  0001140361-26-038056
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Cigna reaffirms 2026 adjusted EPS of at least $30.45, sets 10-14% EPS CAGR target through 2030
--------------------------------------------------------------------------------

- Reaffirms FY2026 outlook: adjusted revenues ~$280B, adjusted EPS at least $30.45, Evernorth adjusted income ≥$6.90B, Cigna Healthcare ≥$4.55B, medical care ratio 83.7%-84.7%.
- New 2026-2030 targets: 10-14% adjusted EPS CAGR and ~$50B in cumulative operating cash flow.
- Announces $3B multi-year modernization and productivity initiatives to fund growth via AI-enabled tools, workflow streamlining and disciplined supplier/vendor management.
- New 'Lead to One' strategy centers on complex-care leadership; CEO Brian Evanko cites Evernorth Specialty & Care Services serving over 1M complex-condition patients and 8M prescriptions annually.
- The Cigna Group Foundation announced a new $10.5M, three-year grant program to expand community support for patients and caregivers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739940/000114036126038056/0001140361-26-038056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739940/000114036126038056/ef20082869_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-038056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer